CS-0777
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CS-0777, covering 2011-03-10 to 2011-03-10. Get the full timeline:
Most recent: Clinical Trial Update: 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients [Phase 1]